Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Single Arm Open-Label Multicenter Study to Assess the Safety, Tolerability and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Adult Women

NCT01107106 is registered in ClinicalTrials.gov with HRA Pharma as lead sponsor.

NCT NCT01107106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Single Arm Open-Label Multicenter Study to Assess the Safety, Tolerability and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Adult Women
Lead sponsor
HRA Pharma
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
February 28, 2013
Enrollment
579 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

contraception